PMID- 35892425 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220824 IS - 2076-3425 (Print) IS - 2076-3425 (Electronic) IS - 2076-3425 (Linking) VI - 12 IP - 8 DP - 2022 Jul 26 TI - A Novel CaMKII Inhibitory Peptide Blocks Relapse to Morphine Seeking by Influencing Synaptic Plasticity in the Nucleus Accumbens Shell. LID - 10.3390/brainsci12080985 [doi] LID - 985 AB - Drugs of abuse cause enduring functional disorders in the brain reward circuits, leading to cravings and compulsive behavior. Although people may rehabilitate by detoxification, there is a high risk of relapse. Therefore, it is crucial to illuminate the mechanisms of relapse and explore the therapeutic strategies for prevention. In this research, by using an animal model of morphine self-administration in rats and a whole-cell patch-clamp in brain slices, we found changes in synaptic plasticity in the nucleus accumbens (NAc) shell were involved in the relapse to morphine-seeking behavior. Compared to the controls, the amplitude of long-term depression (LTD) induced in the medium spiny neurons increased after morphine self-administration was established, recovered after the behavior was extinguished, and increased again during the relapse induced by morphine priming. Intravenous injection of MA, a new peptide obtained by modifying Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) inhibitor "myr-AIP", decreased CaMKII activity in the NAc shell and blocked the reinstatement of morphine-seeking behavior without influence on the locomotor activity. Moreover, LTD was absent in the NAc shell of the MA-pretreated rats, whereas it was robust in the saline controls in which morphine-seeking behavior was reinstated. These results indicate that CaMKII regulates morphine-seeking behavior through its involvement in the change of synaptic plasticity in the NAc shell during the relapse, and MA may be of great value in the clinical treatment of relapse to opioid seeking. FAU - Liu, Zhuo AU - Liu Z AD - People's Public Security University of China, Beijing 100038, China. FAU - Zhang, Jianjun AU - Zhang J AUID- ORCID: 0000-0001-7526-7234 AD - CAS Key Laboratory of Mental Health, Institute of Psychology, Beijing 100101, China. FAU - Miao, Linqing AU - Miao L AUID- ORCID: 0000-0002-1489-0548 AD - Beijing Advanced Innovation Center for Intelligent Robots and Systems, Beijing Institute of Technology, Beijing 100081, China. FAU - Kong, Qingyao AU - Kong Q AD - Department of Anesthesia and Critical Care, The University of Chicago, Chicago, IL 60637, USA. FAU - Liu, Xiaodong AU - Liu X AUID- ORCID: 0000-0001-7424-6829 AD - Beijing Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China. FAU - Yu, Longchuan AU - Yu L AD - School of Life Sciences, Peking University, Beijing 100871, China. LA - eng GR - 31871111/National Natural Science Foundation of China/ GR - 2020088/Youth Innovation Promotion Association CAS/ GR - 2019004/the Key Laboratory of Technology for Drug Prevention and Control in Zhejiang Police College/ PT - Journal Article DEP - 20220726 PL - Switzerland TA - Brain Sci JT - Brain sciences JID - 101598646 PMC - PMC9394410 OTO - NOTNLM OT - Ca2+/calmodulin-dependent protein kinase II OT - long-term depression OT - morphine self-administration OT - nucleus accumbens shell OT - opioids OT - reinstatement OT - relapse OT - synaptic plasticity COIS- The authors declare no conflict of interest. EDAT- 2022/07/28 06:00 MHDA- 2022/07/28 06:01 PMCR- 2022/07/26 CRDT- 2022/07/27 04:53 PHST- 2022/06/20 00:00 [received] PHST- 2022/07/12 00:00 [revised] PHST- 2022/07/23 00:00 [accepted] PHST- 2022/07/27 04:53 [entrez] PHST- 2022/07/28 06:00 [pubmed] PHST- 2022/07/28 06:01 [medline] PHST- 2022/07/26 00:00 [pmc-release] AID - brainsci12080985 [pii] AID - brainsci-12-00985 [pii] AID - 10.3390/brainsci12080985 [doi] PST - epublish SO - Brain Sci. 2022 Jul 26;12(8):985. doi: 10.3390/brainsci12080985.